148 related articles for article (PubMed ID: 33667680)
1. Chitosan/PCL nanoparticles can improve anti-neoplastic activity of 5-fluorouracil in head and neck cancer through autophagy activation.
de Lima JM; Castellano LRC; Bonan PRF; de Medeiros ES; Hier M; Bijian K; Alaoui-Jamali MA; da Cruz Perez DE; da Silva SD
Int J Biochem Cell Biol; 2021 May; 134():105964. PubMed ID: 33667680
[TBL] [Abstract][Full Text] [Related]
2. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.
Badran MM; Mady MM; Ghannam MM; Shakeel F
Int J Biol Macromol; 2017 Feb; 95():643-649. PubMed ID: 27908720
[TBL] [Abstract][Full Text] [Related]
4. 5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.
Anitha A; Chennazhi KP; Nair SV; Jayakumar R
J Biomed Nanotechnol; 2012 Feb; 8(1):29-42. PubMed ID: 22515092
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
6. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
[TBL] [Abstract][Full Text] [Related]
7. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
8. A novel modified chitosan/collagen coated-gold nanoparticles for 5-fluorouracil delivery: Synthesis, characterization, in vitro drug release studies, anti-inflammatory activity and in vitro cytotoxicity assay.
Hongsa N; Thinbanmai T; Luesakul U; Sansanaphongpricha K; Muangsin N
Carbohydr Polym; 2022 Feb; 277():118858. PubMed ID: 34893265
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
Reneeta NP; Thiyonila B; Aathmanathan VS; Ramya T; Chandrasekar P; Subramanian N; Prajapati VK; Krishnan M
Bioconjug Chem; 2018 Sep; 29(9):2994-3009. PubMed ID: 30089206
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB
World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336
[TBL] [Abstract][Full Text] [Related]
11. Functionalized layer-by-layer assembled film with directional 5-fluorouracil release to target colon cancer.
Janardhanam LSL; Indukuri VV; Verma P; Dusane AC; Venuganti VVK
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111118. PubMed ID: 32600718
[TBL] [Abstract][Full Text] [Related]
12. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic Effect of 5-Fluorouracil-loaded Polymer-coated Magnetite Nanographene Oxide Combined with Radiofrequency.
Asadi L; Shirvalilou S; Khoee S; Khoei S
Anticancer Agents Med Chem; 2018; 18(8):1148-1155. PubMed ID: 29623854
[TBL] [Abstract][Full Text] [Related]
15. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
Mishra BJ; Kaul A; Trivedi P
Drug Deliv; 2015 Feb; 22(2):214-22. PubMed ID: 24524408
[TBL] [Abstract][Full Text] [Related]
16. A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide.
Irani M; Mir Mohamad Sadeghi G; Haririan I
Int J Biol Macromol; 2017 Apr; 97():744-751. PubMed ID: 28109815
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil monodispersed chitosan microspheres: Microfluidic chip fabrication with crosslinking, characterization, drug release and anticancer activity.
He T; Wang W; Chen B; Wang J; Liang Q; Chen B
Carbohydr Polym; 2020 May; 236():116094. PubMed ID: 32172896
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
Chen Y; Sun L; Guo D; Wu Z; Chen W
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells.
Xiang Q; Yang Y; Zhou Z; Zhou D; Jin Y; Zhang Z; Huang Y
Eur J Pharm Biopharm; 2012 Feb; 80(2):379-86. PubMed ID: 22101181
[TBL] [Abstract][Full Text] [Related]
20. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
